Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021

…, O Blyuss, P Bobkova, G Bonsel, S Borzakova… - Jama, 2022 - jamanetwork.com
Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …

[HTML][HTML] Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

…, E Samitova, S Borzakova… - European …, 2022 - Eur Respiratory Soc
Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …

[HTML][HTML] Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in …

…, L Mazankova, A Miroshina, E Samitova, S Borzakova… - BMC medicine, 2022 - Springer
Background Previous studies assessing the prevalence of COVID-19 sequelae in adults
and children were performed in the absence of an agreed definition. We investigated …

[HTML][HTML] A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021

…, O Blyuss, P Bobkova, G Bonsel, S Borzakova… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …

[HTML][HTML] Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an …

…, EA Khadorich, VA Gushchin, SN Borzakova… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …

[HTML][HTML] Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different …

…, L Mazankova, A Miroshina, E Samitova, S Borzakova… - BMC medicine, 2024 - Springer
Background Long-term health outcomes in children and young people (CYP) after COVID-19
infection are not well understood and studies with control groups exposed to other …

A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 (preprint)

…, O Blyuss, P Bobkova, G Bonsel, S Borzakova… - 2022 - pesquisa.bvsalud.org
ImportanceWhile much of the attention on the COVID-19 pandemic was directed at the daily
counts of cases and those with serious disease overwhelming health services, increasingly, …

Breastfeeding news: meta-analysis and results of a socio-medical study

LD Muzalevskaya, SN Borzakova… - Meditsinskaya …, 2021 - journals.eco-vector.com
The article reflects the results of an online survey from members of the Internet communities
of mothers and patients of the neonatology department of the State Budgetary Healthcare …

Treatment and prevention of chronic acid-dependent diseases in children-the leading role of gastroprotectors

…, LV Bogomaz, SN Borzakova - Meditsinskaya …, 2021 - cardiosomatics.orscience.ru
The article contains materials on the practical organization of preventive and curative work of
a pediatrician and a nurse at a medical area in relation to children with chronic diseases of …

[HTML][HTML] Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

S Channon-Wells, O Vito, AJ McArdle… - The Lancet …, 2023 - thelancet.com
Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children …